Document Detail

Conference Report: Drug Metabolism Discussion Group Short Meeting: microsampling - the next big thing.
MedLine Citation:
PMID:  23216118     Owner:  NLM     Status:  In-Data-Review    
On behalf of the Drug Metabolism Discussion Group, Regulatory Bioanalysis AstraZeneca (UK) recently organized and hosted an extremely successful Drug Metabolism Discussion Group Short Meeting on 'microsampling - the next big thing'. This attracted over 140 delegates and a strong line up of presenters of respected scientists within the field. This meeting focused on the impact of taking a reduced sample (5-20 µl) from an animal, or later in the clinic, particularly neonates. The agenda covered the spectrum of microsampling, from capillary plasma microsampling, as championed by Ove Jonsson and Kristian Königsson, through to dried blood spots. The day was split up in to three sections, the morning concentrating on the sampling aspects from animals. A highlight of the first section was the 'poster blitz' where four poster presenters gave a quick overview of their work. This introduced the poster session and created a good atmosphere for general debate between the delegates. The mid-session saw the bioanalytical challenges discussed from the discovery to the preclinical stage. To encourage interaction between the presenters and the audience, a panel discussion was used that led to interesting insights into study design from toxicological and bioanalytical viewpoints. The final session was left to clinical aspects of microsampling and a particularly interesting presentation from Hitesh Pandya from the Pediatric Respiratory Medicine Department (University of Leicester, Leicester, UK). An eloquent and hard-hitting presentation put into perspective the importance of advancements in this field that enables sample to be taken in a noninvasive manner. The meeting was well received with excellent feedback from all concerned.
Kirsty Jackson-Addie; Karen Woods; Allan Muir; Christopher Smith; David Higton
Related Documents :
24171918 - Disease identification based on ambulatory drugs dispensation and in-hospital icd-10 di...
25230128 - Jvg9, a benzimidazole derivative, alters the surface and cytoskeleton of trypanosoma cr...
23953948 - Comparisons of polydrug use at national and inner city levels in england: associations ...
24253028 - Use of symptom-relieving drugs before and after surgery for urinary incontinence in wom...
2143458 - Cardiovascular effects of isradipine (lomir) with special emphasis on haemodynamics and...
22641858 - Understanding success and nonsuccess in the drug court.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Bioanalysis     Volume:  4     ISSN:  1757-6199     ISO Abbreviation:  Bioanalysis     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101512484     Medline TA:  Bioanalysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  2775-9     Citation Subset:  IM    
AstraZeneca, Alderley Park, Macclesfield, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Conference Report: The 3rd EBF Focus Meeting: 'Hatching' - emerging technologies approaching the reg...
Next Document:  Simultaneous determination of metoprolol and ?-hydroxymetoprolol in human plasma using excitation-em...